Enanta Pharmaceuticals | ENTA - EPS Earnings Per Share


Enanta Pharmaceuticals reported $-1.05 in EPS Earnings Per Share for its fiscal quarter ending in December of 2024.





Eps Change Date
AbbVie USD 2.71 0.85 Dec/2025
Amgen USD 5.29 0.35 Dec/2025
Anika Therapeutics USD 0.13 0.35 Dec/2025
Arrowhead Research USD 0.22 0.33 Dec/2025
AstraZeneca USD 2.12 0.26 Dec/2025
BioCryst Pharmaceuticals USD 1.17 1.1 Dec/2025
Biogen USD 1.99 2.82 Dec/2025
Bristol-Myers Squibb USD 1.26 0.37 Dec/2025
Enanta Pharmaceuticals USD -1.05 0.31 Dec/2024
Gilead Sciences USD 1.86 0.61 Dec/2025
GlaxoSmithKline GBP 0.26 0.29 Dec/2025
Halozyme Therapeutics USD -0.24 1.96 Dec/2025
Heron Therapeutics USD -0.02 0.02 Dec/2025
Immunic USD -0.24 0.03 Sep/2024
Incyte USD 1.8 0.46 Dec/2025
Insmed USD -1.54 0.21 Dec/2025
Ionis Pharmaceuticals USD -1.41 0.61 Dec/2025
J&J USD 2.7 0.24 Mar/2026
Karyopharm Therapeutics USD -2.22 2.07 Dec/2025
Ligand Pharmaceuticals USD 2.02 1.07 Dec/2025
Merck USD 2.04 0.54 Dec/2025
Neurocrine Biosciences USD 1.88 0.29 Dec/2025
Novartis USD 1.54 0.5 Dec/2025
Novavax USD 0.13 0.59 Dec/2025
Pfizer USD 0.66 0.21 Dec/2025
PTC Therapeutics USD -1.67 1.87 Dec/2025
Roche Holding CHF 8.37 2.95 Dec/2025
Sarepta Therapeutics USD -3.58 3.45 Dec/2025
Vertex Pharmaceuticals USD 5.03 0.23 Dec/2025